December 1, 2015

Gender, Weight and Heart Failure: New Insights on ‘Obesity Survival Paradox’

Only women see benefits of modest excess adiposity

Woman running outdoors

Women with advanced heart failure who are somewhat overweight survive significantly longer than do women who are obese or of normal weight, a new analysis from Cleveland Clinic reveals.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

The same is not true for men. Although women of any weight with heart failure have a survival advantage over men, extra pounds are detrimental to men with the syndrome, the analysis shows.

“Maintaining a healthy body weight is very important for men with heart failure,” says cardiologist Leslie Cho, MD, Director of the Women’s Cardiovascular Center at Cleveland Clinic and principal author of the study on the so-called overweight/obesity survival paradox, which was published in the November 2015 issue of JACC: Heart Failure.

The aim: Clarifying gender’s role

Dr. Leslie Cho

Leslie Cho, MD

An association between extra weight and equal or improved survival in patients with a low ejection fraction has been recognized for several years. Multiple underlying reasons have been postulated but not confirmed. The role of gender has not been fully explored.

The discovery that women’s hearts utilize more fatty acids and less glucose compared with men’s hearts led Dr. Cho and colleagues to suspect this physiologic distinction might explain what protects women’s hearts. She organized a review of patients with advanced systolic heart failure treated at Cleveland Clinic to determine the effect of body mass index (BMI) on mortality in women relative to men.

Advertisement

“We simply wanted to test the hypothesis,” she says.

Study design and findings

The researchers examined the outcomes of 3,811 patients with an ejection fraction ≤ 40 percent who had undergone cardiopulmonary exercise testing at Cleveland Clinic between 1995 and 2011. Patients were categorized by weight as follows:

  • Obese (BMI ≥ 30 kg/m2)
  • Overweight (BMI ≥ 25 but < 30 kg/m2)
  • Normal weight (< 25 kg/m2)

Patients were followed for a mean of 6.2 years. After adjustment for all confounders, mortality rates were higher for overweight and obese men than for normal-weight men and for women of any weight.

Conversely, overweight women were found to survive 16 percent longer than women of normal weight and 19 percent longer than obese women.

“Greater myocardial fatty acid uptake and lower myocardial glucose utilization may be an effect of estrogen,” notes Dr. Cho. “This raises the possibility that women’s hearts are more dependent on fatty acids for energy production than male hearts are, potentially explaining the survival advantage of females with excess adiposity.”

Advertisement

Implications for practice: No license to put on pounds

The study was undertaken purely to test a scientific hypothesis and should not be construed as a license for women to gain weight, Dr. Cho warns. “Obesity remains a key determinant of cardiovascular health,” she says. Indeed, obesity (as opposed to overweight) did not confer a survival advantage among the study’s female cohort.

An editorial accompanying the study in JACC: Heart Failure concurs, concluding that efforts to prevent obesity, especially in its more severe forms, are needed in patients with heart failure. The editorial points out that Dr. Cho’s study echoes the “obesity paradox” found in previous studies of survival in heart failure but notes that this new study “had longer follow-up and a better assessment of potential confounders.”

Further research is needed to understand why modest excess adiposity appears to have a favorable biological impact on females, Dr. Cho notes.

“Greater understanding may reveal new therapeutic opportunities in advanced heart failure and also enable more accurate counseling of heart failure patients regarding weight management,” she says.

Related Articles

21-HVI-2541213_chest-pain_650x450
December 14, 2021
New Guideline Helps Evaluate Risk in Patients With Chest Pain

Further acute testing not needed if ECG and high-sensitivity troponin are negative

20-HVI-1987645-scott-cameron-md-phd_650x450
November 6, 2020
New Head of Vascular Medicine Looks to Enhance Collaborative Caregiving

Scott Cameron, MD, PhD, also brings wide-ranging research interests to bear

20-HVI-1961368_Matthew-Thompson_650x450
September 30, 2020
Dr. Matthew Thompson Brings a Distinctly International Perspective to Endovascular Interventions

Pioneering U.K. vascular surgeon joins Cleveland Clinic

20-HVI-1961369-acute-stroke-in-brain_650x450
September 24, 2020
Stroke Risk in Cardiac Surgery: New Guidance for Averting a Dreaded Complication

AHA statement is first comprehensive document on perioperative stroke reduction

20-HVI-1896881 vascular-surgery-650&#215;450
July 17, 2020
Cleveland Clinic Earns 3 Stars in Vascular Quality Initiative Registry Participation Program

Recognition reflects prioritization of long-term patient outcomes

20-HVI-1898975 Singh_Guidelines on CV imaging in athletes_CQD_650x450_993744768
June 15, 2020
First Formal Guidance Issued on Multimodality Cardiac Imaging in Young Athletes

Recommendations help distinguish exercise-induced remodeling from pathology

20-HVI-1894191-Primary-prevention-of-CVD-in-women
May 29, 2020
Guideline Update on Primary Cardiovascular Prevention in Women Takes on Conventional and Sex-Specific Risks

JACC review highlights factors unique to women, ways to tailor management

20-HVI-1892867-ablation-roundup-650&#215;450
May 12, 2020
Trio of Studies at Virtual HRS Meeting Showcase Catheter Ablation Advances

Pushing the envelope in ablation of atrial fibrillation, ventricular tachycardia

Ad